ADOR develops a point-of-care molecular diagnostics platform utilizing multiplex syndromic panels for the rapid identification of infectious diseases and antibiotic resistance. The system delivers results in 30-45 minutes, enabling immediate clinical decision-making in response to emerging pathogens.
Funding
$17.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional laboratory-based molecular diagnostic testing for infectious diseases often involves lengthy turnaround times and complex workflows, hindering timely clinical decision-making, especially in point-of-care settings. The need for specialized equipment and trained personnel further limits accessibility, particularly in resource-constrained environments.
Solution
ADOR's NATlab platform offers rapid, point-of-care molecular diagnostics using multiplex syndromic panels to identify infectious diseases and antibiotic resistance markers directly at the patient's side. The system employs a "sample-to-answer" approach, integrating microfluidic cartridges and a compact benchtop device to automate the entire testing process. Utilizing proprietary isothermal amplification assay and carbon array detection, NATlab delivers accurate results in 30-45 minutes, enabling immediate clinical decisions and appropriate treatment strategies. The platform's connectivity features also facilitate geographical mapping of test results for outbreak detection and management.
Target Audience
The primary target audience includes healthcare providers in hospitals, clinics, and point-of-care settings who require rapid and accurate diagnostic information for infectious diseases, as well as public health organizations involved in outbreak surveillance and management.
Features
- Multiplex syndromic panels for simultaneous detection of up to 100 different pathogens/genomic targets in a single test
- Proprietary rolling circle amplification assay for high sensitivity and specificity
- IP-protected microfluidic cartridge designed for isothermal amplification
- Unique carbon array detection system
- Fully automated "sample-to-answer" operation, minimizing hands-on time and training requirements
- Connectivity for geographical mapping of test results and outbreak detection
- Easy panel modification for fast response to new emerging pathogens and strains